These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21421545)

  • 1. Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels.
    Penney KL; Schumacher FR; Kraft P; Mucci LA; Sesso HD; Ma J; Niu Y; Cheong JK; Hunter DJ; Stampfer MJ; Hsu SI
    Carcinogenesis; 2011 Jun; 32(6):853-9. PubMed ID: 21421545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels.
    Parikh H; Wang Z; Pettigrew KA; Jia J; Daugherty S; Yeager M; Jacobs KB; Hutchinson A; Burdett L; Cullen M; Qi L; Boland J; Collins I; Albert TJ; Vatten LJ; Hveem K; Njølstad I; Cancel-Tassin G; Cussenot O; Valeri A; Virtamo J; Thun MJ; Feigelson HS; Diver WR; Chatterjee N; Thomas G; Albanes D; Chanock SJ; Hunter DJ; Hoover R; Hayes RB; Berndt SI; Sampson J; Amundadottir L
    Hum Genet; 2011 Jun; 129(6):675-85. PubMed ID: 21318478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer.
    Klein RJ; Halldén C; Cronin AM; Ploner A; Wiklund F; Bjartell AS; Stattin P; Xu J; Scardino PT; Offit K; Vickers AJ; Grönberg H; Lilja H
    Cancer Prev Res (Phila); 2010 May; 3(5):611-9. PubMed ID: 20424135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kallikarein-related peptidase 3 common genetic variant and the risk of prostate cancer.
    Motamedi RK; Sarhangi N; Afshari M; Sattari M; Jamaldini SH; Samzadeh M; Mohsen Ziaei SA; Pourmand GR; Hasanzad M
    J Cell Biochem; 2019 Sep; 120(9):14822-14830. PubMed ID: 31017705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic correction of PSA values using sequence variants associated with PSA levels.
    Gudmundsson J; Besenbacher S; Sulem P; Gudbjartsson DF; Olafsson I; Arinbjarnarson S; Agnarsson BA; Benediktsdottir KR; Isaksson HJ; Kostic JP; Gudjonsson SA; Stacey SN; Gylfason A; Sigurdsson A; Holm H; Bjornsdottir US; Eyjolfsson GI; Navarrete S; Fuertes F; Garcia-Prats MD; Polo E; Checherita IA; Jinga M; Badea P; Aben KK; Schalken JA; van Oort IM; Sweep FC; Helfand BT; Davis M; Donovan JL; Hamdy FC; Kristjansson K; Gulcher JR; Masson G; Kong A; Catalona WJ; Mayordomo JI; Geirsson G; Einarsson GV; Barkardottir RB; Jonsson E; Jinga V; Mates D; Kiemeney LA; Neal DE; Thorsteinsdottir U; Rafnar T; Stefansson K
    Sci Transl Med; 2010 Dec; 2(62):62ra92. PubMed ID: 21160077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between KLK3 rs2735839 G/A polymorphism and serum PSA levels in Japanese men.
    Nobata S; Hishida A; Naito M; Asai Y; Mori A; Kuwabara M; Katase S; Okada R; Morita E; Kawai S; Hamajima N; Wakai K
    Urol Int; 2012; 89(1):39-44. PubMed ID: 22433834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide association study of serum prostate-specific antigen levels based on 1000 Genomes imputed data in Japanese: the Japan Multi-Institutional Collaborative Cohort Study.
    Hishida A; Nakatochi M; Tamura T; Nagayoshi M; Okada R; Kubo Y; Tsukamoto M; Kadomatsu Y; Suzuki S; Nishiyama T; Kuriyama N; Watanabe I; Takezaki T; Nishimoto D; Kuriki K; Arisawa K; Katsuura-Kamano S; Mikami H; Kusakabe M; Oze I; Koyanagi YN; Nakamura Y; Kadota A; Shimanoe C; Tanaka K; Ikezaki H; Murata M; Kubo M; Momozawa Y; Takeuchi K; Wakai K;
    Nagoya J Med Sci; 2021 Feb; 83(1):183-194. PubMed ID: 33727749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive resequence analysis of the KLK15-KLK3-KLK2 locus on chromosome 19q13.33.
    Parikh H; Deng Z; Yeager M; Boland J; Matthews C; Jia J; Collins I; White A; Burdett L; Hutchinson A; Qi L; Bacior JA; Lonsberry V; Rodesch MJ; Jeddeloh JA; Albert TJ; Halvensleben HA; Harkins TT; Ahn J; Berndt SI; Chatterjee N; Hoover R; Thomas G; Hunter DJ; Hayes RB; Chanock SJ; Amundadottir L
    Hum Genet; 2010 Jan; 127(1):91-9. PubMed ID: 19823874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between three genetic variants in kallikrein 3 and prostate cancer risk.
    Ding WH; Ren KW; Yue C; Zou JG; Zuo L; Zhang LF; Bai Y; Okada A; Yasui T; Mi YY
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30413614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation in KLK2 and KLK3 is associated with concentrations of hK2 and PSA in serum and seminal plasma in young men.
    Sävblom C; Halldén C; Cronin AM; Säll T; Savage C; Vertosick EA; Klein RJ; Giwercman A; Lilja H
    Clin Chem; 2014 Mar; 60(3):490-9. PubMed ID: 24270797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association study between common variations in some candidate genes and prostate adenocarcinoma predisposition through multi-stage approach in Iranian population.
    Beikzadeh B; Angaji SA; Abolhasani M
    BMC Med Genet; 2020 Apr; 21(1):81. PubMed ID: 32295536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript.
    Kote-Jarai Z; Amin Al Olama A; Leongamornlert D; Tymrakiewicz M; Saunders E; Guy M; Giles GG; Severi G; Southey M; Hopper JL; Sit KC; Harris JM; Batra J; Spurdle AB; Clements JA; Hamdy F; Neal D; Donovan J; Muir K; Pharoah PD; Chanock SJ; Brown N; Benlloch S; Castro E; Mahmud N; O'Brien L; Hall A; Sawyer E; Wilkinson R; Easton DF; Eeles RA
    Hum Genet; 2011 Jun; 129(6):687-94. PubMed ID: 21465221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphism and prostate cancer aggressiveness: a case-only study of 1,536 GWAS and candidate SNPs in African-Americans and European-Americans.
    Bensen JT; Xu Z; Smith GJ; Mohler JL; Fontham ET; Taylor JA
    Prostate; 2013 Jan; 73(1):11-22. PubMed ID: 22549899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide association study identified novel genetic variant on SLC45A3 gene associated with serum levels prostate-specific antigen (PSA) in a Chinese population.
    Sun J; Tao S; Gao Y; Peng T; Tan A; Zhang H; Yang X; Qin X; Hu Y; Feng J; Kim ST; Lin X; Wu Y; Zhang J; Li Z; Li L; Mo L; Liang Z; Shi D; Huang Z; Huang X; Liu M; Liu Q; Zhang S; Lilly Zheng S; Xu J; Mo Z
    Hum Genet; 2013 Apr; 132(4):423-9. PubMed ID: 23269536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prostate cancer susceptibility variant rs2735839 near KLK3 gene is associated with aggressive prostate cancer and can stratify gleason score 7 patients.
    He Y; Gu J; Strom S; Logothetis CJ; Kim J; Wu X
    Clin Cancer Res; 2014 Oct; 20(19):5133-5139. PubMed ID: 25274378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very low PSA concentrations and deletions of the KLK3 gene.
    Rodriguez S; Al-Ghamdi OA; Burrows K; Guthrie PA; Lane JA; Davis M; Marsden G; Alharbi KK; Cox A; Hamdy FC; Neal DE; Donovan JL; Day IN
    Clin Chem; 2013 Jan; 59(1):234-44. PubMed ID: 23169475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility.
    Lai J; Kedda MA; Hinze K; Smith RL; Yaxley J; Spurdle AB; Morris CP; Harris J; Clements JA
    Carcinogenesis; 2007 May; 28(5):1032-9. PubMed ID: 17151093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KLK3 SNP-SNP interactions for prediction of prostate cancer aggressiveness.
    Lin HY; Huang PY; Cheng CH; Tung HY; Fang Z; Berglund AE; Chen A; French-Kwawu J; Harris D; Pow-Sang J; Yamoah K; Cleveland JL; Awasthi S; Rounbehler RJ; Gerke T; Dhillon J; Eeles R; Kote-Jarai Z; Muir K; ; Schleutker J; Pashayan N; ; Neal DE; Nielsen SF; Nordestgaard BG; Gronberg H; Wiklund F; Giles GG; Haiman CA; Travis RC; Stanford JL; Kibel AS; Cybulski C; Khaw KT; Maier C; Thibodeau SN; Teixeira MR; Cannon-Albright L; Brenner H; Kaneva R; Pandha H; ; Srinivasan S; Clements J; Batra J; Park JY
    Sci Rep; 2021 Apr; 11(1):9264. PubMed ID: 33927218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kallikrein-related peptidase 3 (KLK3/PSA) single nucleotide polymorphisms and ovarian cancer survival.
    O'Mara TA; Nagle CM; Batra J; Kedda MA; Clements JA; Spurdle AB
    Twin Res Hum Genet; 2011 Aug; 14(4):323-7. PubMed ID: 21787114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the prostate specific antigen (PSA/KLK3) correlate with male infertility.
    Gupta N; Sudhakar DVS; Gangwar PK; Sankhwar SN; Gupta NJ; Chakraborty B; Thangaraj K; Gupta G; Rajender S
    Sci Rep; 2017 Sep; 7(1):11225. PubMed ID: 28894123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.